| Literature DB >> 30941375 |
Zheng Liu1,2, Jun Wang1,2, Gong-Zhou Chen1,2, Wei-Wei Li1,2, Yun-Qi Wu2, Xiao Xiao1,2, Yi-Lu Zhang2, Yan Yang1,2, Wen-Kai Hu1,2, Zhi-Cheng Sun1,2, Xi-Yang Wang1,2.
Abstract
In this retrospective study, charts of inpatients with spinal tuberculosis (STB) treated in large-scale general hospitals in Changsha, Hunan, China, between 2007 and 2016 were reviewed to investigate their clinical characteristics. Demographic, epidemiological and clinical features, imaging findings, treatment methods, and prognosis were summarized and analyzed. There were 1378 patients, 805 males and 573 females, with a mean age of 43.7 years. The mean interval between symptom onset and diagnosis was 16.0 months (range 15 days-240 months). The incidence of back pain, radicular pain and symptoms of systemic toxicity was 92.5%, 40.1%, and 32.1%, respectively. The rate of neurological impairment was 49.9 %. STB was present in two or more vertebrae in 91.1% of patients, with two adjacent vertebrae being involved in 67.9% of them. The lumbar segment (38.2%) was the most frequently affected, followed by the thoracic spine (35.7%). The sacrococcygeal area was the least frequently involved (0.8%). Abscesses were detected in 65.5% of patients. One thousand patients (72.6%) were managed with surgery and 378 (27.4%) with anti-TB drugs only. Cure was achieved in 1215 patients (88.2%), whereas 49 (3.5 %) had relapses. Concomitant pulmonary TB (PTB) was diagnosed in 366 patients (26.6%) and 63 (4.6%) had concomitant diabetes. Compared with the previous five years, the number of older patients, urban patients, and medical staff with STB had increased by 6.1%, 5.2%, and 1.3%, respectively in the five years studied. STB remains a severe public health problem that cannot be ignored. Most of the patients ignored early symptoms and therefore received untimely treatment. Thus, surveillance for and treatment of STB in South-central China requires strengthening. In addition to the current China-wide database of patients with PTB, a China-wide database of patients with STB should also be set up.Entities:
Mesh:
Year: 2019 PMID: 30941375 PMCID: PMC6421015 DOI: 10.1155/2019/9765253
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Demographics and epidemiology of inpatients with STB.
| Year | Gender | Age (yeas) | Residence | Occupation | Total | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Male | Female | <18 | 18~45 | 46~60 | >60 | Rural | Urban | Farmer | Worker | Student | Others | ||
| 2007 | 70 | 46 | 7 | 53 | 42 | 14 | 84 | 32 | 59 | 24 | 10 | 23 | 116 |
| 2008 | 82 | 56 | 11 | 58 | 41 | 28 | 96 | 42 | 67 | 30 | 12 | 29 | 138 |
| 2009 | 65 | 58 | 15 | 52 | 33 | 23 | 91 | 32 | 65 | 22 | 16 | 20 | 123 |
| 2010 | 86 | 60 | 10 | 66 | 38 | 32 | 122 | 24 | 75 | 24 | 14 | 33 | 146 |
| 2011 | 75 | 56 | 6 | 61 | 33 | 31 | 101 | 30 | 71 | 21 | 9 | 30 | 131 |
| 2012 | 91 | 60 | 10 | 71 | 31 | 39 | 115 | 36 | 69 | 30 | 13 | 39 | 151 |
| 2013 | 79 | 69 | 13 | 59 | 43 | 33 | 99 | 49 | 65 | 28 | 14 | 41 | 148 |
| 2014 | 75 | 46 | 6 | 42 | 47 | 26 | 76 | 45 | 56 | 21 | 7 | 47 | 121 |
| 2015 | 101 | 69 | 11 | 63 | 46 | 50 | 122 | 48 | 79 | 27 | 17 | 47 | 170 |
| 2016 | 81 | 53 | 11 | 36 | 49 | 38 | 97 | 37 | 53 | 32 | 16 | 33 | 134 |
|
| |||||||||||||
| Total | 805 | 573 | 100 | 561 | 403 | 314 | 1003 | 375 | 659 | 259 | 128 | 332 | 1378 |
| Rate (%) | 58.4 | 41.6 | 7.3 | 40.7 | 29.2 | 22.8 | 72.8 | 27.2 | 47.8 | 18.8 | 9.3 | 24.1 | |
|
| 4.583 | 46.592 | 20.252 | 30.756 | |||||||||
| P | 0.869 | 0.011 | 0.016 | 0.281 | |||||||||
Figure 1The distribution of patients with STB in Hunan province is shown: 214 (15.53%) were from Changsha (J), 161 (11.68%) from Shaoyang (G), 130 (9.43%) from Yueyang (D), 128 (9.29%) from Yiyang (E), 121 (8.78%) from Loudi (H), 111 (8.06%) from Yongzhou (M), 92 (6.68%) from Hengyang (L), 89 (6.46%) from Zhuzhou (K), 82 (5.95%) from Changde (C), 51(3.70%) from Xiangtan (I), 42 (3.05%) from Zhangjiajie (B), 30 (2.18%) from Chenzhou (N), 41 (2.98%) from Huaihua (F), and 26 (1.89%) from Xiangxi (A).
Clinical presentation of inpatients with STB.
| Year | Back pain | Radiating pain | Systemic toxicity symptoms | Neurological injury | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| (ASIA grade) | |||||||||||
| Yes | No | Yes | No | Yes | No | A | B | C | D | E | |
| 2007 | 108 | 8 | 55 | 61 | 38 | 78 | 2 | 3 | 6 | 50 | 55 |
| 2008 | 127 | 11 | 60 | 78 | 47 | 91 | 1 | 2 | 10 | 58 | 67 |
| 2009 | 109 | 14 | 49 | 74 | 39 | 84 | 2 | 2 | 14 | 40 | 65 |
| 2010 | 134 | 12 | 51 | 95 | 44 | 102 | 1 | 3 | 13 | 64 | 65 |
| 2011 | 118 | 13 | 49 | 82 | 47 | 84 | 3 | 2 | 13 | 50 | 63 |
| 2012 | 142 | 9 | 52 | 99 | 66 | 85 | 4 | 5 | 12 | 52 | 78 |
| 2013 | 139 | 9 | 59 | 89 | 37 | 111 | 2 | 6 | 8 | 61 | 71 |
| 2014 | 116 | 5 | 56 | 65 | 29 | 92 | 1 | 3 | 11 | 33 | 73 |
| 2015 | 154 | 16 | 56 | 114 | 52 | 118 | 2 | 6 | 9 | 52 | 101 |
| 2016 | 128 | 6 | 65 | 69 | 44 | 90 | 3 | 6 | 15 | 57 | 53 |
|
| |||||||||||
| Total | 1275 | 103 | 552 | 826 | 443 | 935 | 21 | 38 | 111 | 517 | 691 |
| Rate (%) | 92.5 | 7.5 | 40.1 | 59.9 | 32.1 | 67.9 | 1.5 | 2.8 | 8.1 | 37.5 | 50.1 |
|
| 9.607 | 16.782 | 18.017 | 26.902 | |||||||
| P | 0.383 | 0.052 | 0.035 | 0.081 | |||||||
Imaging findings of inpatients with STB.
| Year | Lesion sites | Involved number of vertebrae | Abscess | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C | CT | T | TL | L | LS | S | 1 | 2 | ≧3 | With | Without | |
| 2007 | 6 | 5 | 53 | 7 | 39 | 6 | 0 | 10 | 81 | 25 | 75 | 41 |
| 2008 | 8 | 8 | 59 | 11 | 40 | 11 | 1 | 16 | 92 | 30 | 87 | 51 |
| 2009 | 5 | 4 | 49 | 16 | 39 | 9 | 1 | 12 | 86 | 25 | 80 | 43 |
| 2010 | 11 | 3 | 59 | 12 | 47 | 13 | 1 | 17 | 104 | 25 | 98 | 48 |
| 2011 | 2 | 7 | 52 | 12 | 47 | 9 | 2 | 6 | 85 | 40 | 89 | 42 |
| 2012 | 8 | 1 | 55 | 10 | 60 | 14 | 3 | 13 | 101 | 37 | 109 | 42 |
| 2013 | 11 | 3 | 49 | 9 | 68 | 8 | 0 | 14 | 97 | 37 | 90 | 58 |
| 2014 | 12 | 2 | 28 | 14 | 52 | 12 | 1 | 10 | 79 | 32 | 81 | 40 |
| 2015 | 12 | 2 | 53 | 10 | 80 | 11 | 2 | 15 | 124 | 31 | 112 | 58 |
| 2016 | 13 | 6 | 35 | 8 | 55 | 17 | 0 | 10 | 86 | 38 | 82 | 52 |
|
| ||||||||||||
| Total | 88 | 41 | 492 | 109 | 527 | 110 | 11 | 123 | 935 | 320 | 903 | 475 |
| Rate (%) | 6.4 | 3.0 | 35.7 | 7.9 | 38.2 | 8.0 | 0.8 | 8.9 | 67.9 | 23.2 | 65.5 | 34.5 |
|
| 81.027 | 17.655 | 6.582 | |||||||||
| P | 0.01 | 0.479 | 0.681 | |||||||||
C: Cervical; CT: Cervicothoracic; T: Thoracic; TL: Thoracolumbar; L: Lumbar; LS: Lumbosacral; S: Sacrococcygeal.
Figure 2Number of patients treated by surgery or anti-TB chemotherapy only in each year.
Figure 3Number of patients with various outcomes in each year.
Figure 4Number of patients with and without concomitant PTB in each year.
Figure 5Number of patients with and without concomitant diabetes in each year.
Correlation analysis between STB and PTB.
| Variate | Type | Without PTB | With PTB | Total |
| P | ||
|---|---|---|---|---|---|---|---|---|
| N | % | N | % | |||||
| Gender | Male | 573 | 56.6 | 232 | 63.4 | 805 | 5.068 | 0.024 |
| Female | 439 | 43.4 | 134 | 36.6 | 573 | |||
| Abscess | Yes | 644 | 63.6 | 259 | 70.8 | 903 | 6.047 | 0.014 |
| No | 368 | 36.4 | 107 | 29.2 | 475 | |||
| Surgery | Yes | 776 | 76.7 | 224 | 61.2 | 1000 | 32.347 | 0.000 |
| No | 236 | 23.3 | 142 | 38.8 | 378 | |||
| Systemic toxicity symptoms | Yes | 305 | 30.1 | 138 | 37.7 | 443 | 7.055 | 0.008 |
| No | 707 | 69.9 | 228 | 62.3 | 935 | |||
| Neurological injury | Yes | 480 | 47.4 | 207 | 56.6 | 687 | 8.955 | 0.003 |
| No | 532 | 52.6 | 159 | 43.4 | 691 | |||
| Prognosis | Cure | 891 | 88.0 | 319 | 87.2 | 1214 | 0.490 | 0.484 |
| Others | 121 | 12.0 | 47 | 12.8 | 163 | |||
Correlation analysis between STB and diabetes.
| Variate | Type | Without diabetes | With diabetes | Total |
| P | ||
|---|---|---|---|---|---|---|---|---|
| N | % | N | % | |||||
| Age (yeas) | >45 | 662 | 50.3 | 55 | 87.3 | 717 | 32.904 | 0.000 |
| ≦45 | 653 | 49.7 | 8 | 12.7 | 661 | |||
| Systemic toxicity symptoms | Yes | 415 | 31.6 | 28 | 44.4 | 443 | 4.576 | 0.032 |
| No | 900 | 68.4 | 35 | 55.6 | 935 | |||
| Surgery | Yes | 966 | 73.4 | 34 | 54.0 | 1000 | 11.474 | 0.001 |
| No | 349 | 26.6 | 29 | 46.0 | 378 | |||
| Prognosis | Cure | 1167 | 88.7 | 48 | 76.2 | 1215 | 9.086 | 0.003 |
| Others | 148 | 11.3 | 15 | 23.8 | 163 | |||
Comparison of 10 years' data.
| Variate | Type | Group A | Group B | Total |
| P | ||
|---|---|---|---|---|---|---|---|---|
| (2007-2011) | (2012-2016) | |||||||
| N | % | N | % | |||||
| Gender | Male | 378 | 57.8 | 427 | 59 | 805 | 0.197 | 0.657 |
| Female | 276 | 42.2 | 297 | 41 | 573 | |||
| Age (yeas) | ≦60 | 526 | 80.4 | 538 | 74.3 | 1064 | 7.312 | 0.007 |
| >60 | 128 | 19.6 | 186 | 25.7 | 314 | |||
| Residence | Rural | 494 | 75.5 | 509 | 70.3 | 1003 | 4.747 | 0.029 |
| Urban | 160 | 24.5 | 215 | 29.7 | 375 | |||
| Occupation | Medical staff | 6 | 0.9 | 16 | 2.2 | 22 | 4.154 | 0.046 |
| Others | 648 | 99.1 | 708 | 97.8 | 1356 | |||
| Back pain | Yes | 596 | 91.1 | 679 | 93.8 | 1275 | 3.497 | 0.061 |
| No | 58 | 8.9 | 45 | 6.2 | 103 | |||
| Radicular pain | Yes | 264 | 40.4 | 288 | 39.6 | 552 | 0.049 | 0.825 |
| No | 390 | 59.6 | 436 | 60.4 | 826 | |||
| Systemic toxicity symptoms | Yes | 215 | 32.9 | 228 | 31.5 | 443 | 0.301 | 0.583 |
| No | 439 | 67.1 | 496 | 68.5 | 935 | |||
| Abscess | Yes | 429 | 65.6 | 474 | 65.5 | 903 | 0.002 | 0.964 |
| No | 225 | 34.4 | 250 | 34.5 | 475 | |||
| Neurological injury | Yes | 339 | 51.8 | 348 | 48.1 | 687 | 1.952 | 0.162 |
| No | 315 | 48.2 | 376 | 51.9 | 691 | |||
| Involved number of vertebrae | <3 | 509 | 77.8 | 549 | 75.9 | 1058 | 0.771 | 0.380 |
| ≧3 | 145 | 22.2 | 175 | 24.1 | 320 | |||
| Surgery | Yes | 488 | 68.5 | 512 | 70.7 | 1000 | 2.625 | 0.105 |
| No | 166 | 31.5 | 212 | 29.3 | 378 | |||
| PTB | Yes | 176 | 26.9 | 190 | 26.2 | 366 | 0.079 | 0.779 |
| No | 478 | 73.1 | 534 | 73.8 | 1012 | |||
| Diabetes | Yes | 23 | 3.5 | 40 | 5.5 | 63 | 3.176 | 0.075 |
| No | 631 | 96.5 | 684 | 94.5 | 1315 | |||
| Prognosis | Cure | 567 | 86.7 | 648 | 89.5 | 1215 | 2.593 | 0.107 |
| Others | 87 | 13.3 | 76 | 11.9 | 163 | |||